Research has changed what it means to live with myasthenia gravis. Over the past several decades, advances in diagnosis, our understanding of the immune system, and the development of new therapies have expanded options for people living with MG. But there is still more to discover. In 2026, Conquer MG remains committed to supporting research… Read more »
Posts Categorized: blog
2026 Snowflake Shuffle Recap!
❄️2026 Snowflake Shuffle Recap!❄️ The 14th Annual Snowflake Shuffle for MG was a bright, feel-good day full of connection and community. Friends, families, and supporters came out to Berens Park to raise awareness for Myasthenia Gravis and show up for the people affected by it. The vibe was relaxed and positive, with people chatting,… Read more »
argenx Announces U.S. FDA Approval Expanding VYVGART and VYVGART Hytrulo for Use in All Adult Patients Living with gMG
argenx | argenx Announces U.S. FDA Approval Expanding VYVGART and VYVGART Hytrulo for Use in All Adult Patients Living with gMG We are pleased to share an important update from argenx regarding the treatment landscape for generalized myasthenia gravis (gMG). The U.S. Food and Drug Administration (FDA) has approved a label expansion for VYVGART (efgartigimod… Read more »
